Mirum Pharmaceuticals (MIRM) Change in Acquisitions & Divestments (2019 - 2026)

Mirum Pharmaceuticals' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $33.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 94.41% year-over-year to $33.9 million; the TTM figure through Mar 2026 stood at $90.9 million (up 143.48% YoY), while the FY2025 annual figure was $74.4 million, up 274.11% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $33.9 million, up from $13.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $64.5 million in Q1 2023, with the low at $3.0 million in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $27.0 million (2022), against an average of $28.1 million.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments slumped 88.89% in 2023, then surged 304.8% in 2024.
• Mirum Pharmaceuticals' Change in Acquisitions & Divestments stood at $27.0 million in 2022, then plunged by 88.89% to $3.0 million in 2023, then soared by 304.8% to $12.1 million in 2024, then gained by 7.94% to $13.1 million in 2025, then soared by 158.56% to $33.9 million in 2026.
• Business Quant data shows MIRM's Change in Acquisitions & Divestments at $33.9 million in Q1 2026, $13.1 million in Q4 2025, and $18.8 million in Q3 2025.